Dataset Information


Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.

ABSTRACT: Natural killer (NK) cells, a cytotoxic lymphocyte lineage, are able to kill tumor cells in vitro and in mouse models. However, whether these cells display an anti-tumor activity in cancer patients has not been demonstrated. Here we have addressed this issue in patients with several hematological cancers. We found a population of highly activated CD56(dim)CD16(+) NK cells that have recently degranulated, evidence of killing activity, and it is absent in healthy donors. A high percentage of these cells expressed natural killer cell p46-related protein (NKp46), natural-killer group 2, member D (NKG2D) and killer inhibitory receptors (KIRs) and a low percentage expressed NKG2A and CD94. They are also characterized by a high metabolic activity and active proliferation. Notably, we found that activated NK cells from hematological cancer patients have non-NK tumor cell antigens on their surface, evidence of trogocytosis during tumor cell killing. Finally, we found that these activated NK cells are distinguished by their CD45RA(+)RO(+) phenotype, as opposed to non-activated cells in patients or in healthy donors displaying a CD45RA(+)RO(-) phenotype similar to naïve T cells. In summary, we show that CD45RA(+)RO(+) cells, which resemble a unique NK population, have recognized tumor cells and degranulate in patients with hematological neoplasias.

SUBMITTER: Krzywinska E 

PROVIDER: S-EPMC4634619 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4839597 | BioStudies
2020-01-01 | S-EPMC7226455 | BioStudies
2014-01-01 | S-EPMC3980609 | BioStudies
2020-01-01 | S-EPMC7407972 | BioStudies
1000-01-01 | S-EPMC4912059 | BioStudies
2018-01-01 | S-EPMC5948955 | BioStudies
2015-01-01 | S-EPMC4429635 | BioStudies
2015-01-01 | S-EPMC4397864 | BioStudies
1000-01-01 | S-EPMC6048882 | BioStudies
2020-01-01 | S-EPMC7772419 | BioStudies